Naveris
Pre-clinicalNaveris develops highly sensitive blood tests that identify viral cancers significantly earlier than scans or traditional biopsies.
Founded
2018
Focus
Diagnostics
About
Naveris develops highly sensitive blood tests that identify viral cancers significantly earlier than scans or traditional biopsies.
Funding History
1Total raised: $14M
Series A$14MNorthpond VenturesMar 15, 2021
Company Info
TypePrivate
Founded2018
LocationNatick, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile